Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
November 20, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global metastatic colorectal cancer market is estimated to reach a...
Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001
November 19, 2024 04:00 ET
|
AKAMPION
THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 Munich,...
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - Develop Comprehensive Care Protocols & Improve Access to Treatments
October 25, 2024 10:56 ET
|
Research and Markets
Dublin, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By...
Checkpoint Inhibitor Refractory Cancer (PD-L1 and PD-1) Market Research Report 2024-2030: Biomarker Testing Revolutionizes Treatment, Personalized Medicine and Immunotherapy Bolster Growth
October 23, 2024 06:33 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Checkpoint Inhibitor Refractory Cancer Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application, End-User,...
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
October 15, 2024 08:00 ET
|
Immuneering Corporation
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030
October 14, 2024 10:54 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.A...
Neuroendocrine Tumors (NETs) Market Research 2024-2030 with Analyst Recommendations - Establishment of Specialist Therapeutic Centers / Organize Campaigns to Raise Awareness
October 01, 2024 06:48 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of...
Multiple Myeloma Therapeutics Market to hit USD 44.2 billion by 2032, says Global Market Insights Inc.
September 30, 2024 02:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Multiple Myeloma Therapeutics Market size was at approximately USD 25.4 billion in 2023 and will grow at 6.4% CAGR from 2024 to 2032,...
AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
September 24, 2024 03:00 ET
|
AlgoTX
PARIS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced...
NTRK Fusion Gene Positive Advanced Solid Tumors Strategic Business Report 2024, with Coverage of Major Players such as Amoy Diagnostics, AnHeart Therapeutics, ARUP Laboratories, EntroGen and More
September 17, 2024 08:00 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "NTRK Fusion Gene Positive Advanced Solid Tumors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global...